Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

HER2-positive Breast Cancer 1

Interventions

Specimen Handling 334 Magnetic Resonance Spectroscopy 334 Radiotherapy 315 Cyclophosphamide 295 pembrolizumab 281 Cisplatin 267 Carboplatin 245 Drug Therapy 237 Blood Specimen Collection 233 Biopsy 204 Bevacizumab 186 Gemcitabine 178 venetoclax 172 Radiosurgery 169 Capecitabine 164 Oxaliplatin 163 fludarabine 161 Nivolumab 156 Paclitaxel 155 Standard of Care 136 Surveys and Questionnaires 130 Surgical Procedures, Operative 130 Dexamethasone 126 Fluorouracil 124 Docetaxel 113 tislelizumab 110 Rituximab 110 Cytarabine 104 Azacitidine 101 atezolizumab 100

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER × Isovaleryl-CoA Dehydrogenase × Clear all

NCT07281001 2025-12-15

Traderrus

Blokhin's Russian Cancer Research Center

Phase NA Recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡